| Literature DB >> 35936306 |
Haixia Hao1, Lihong Guo1, Jianwei Dong1.
Abstract
In recent years, venture capital (VC) cross-border syndication has shown an obvious growth trend. Based on the existing studies, this paper explores the impact of VC cross-border syndication on corporate innovation. We also examine the mediating roles of cross-border quadratic relationship closure (CBQRC) formed by the strategic cooperation relationship between the respective portfolio companies of domestic and foreign VCs. This paper conducted an empirical analysis to test our hypotheses using a sample of first-round investments in domestic firms by domestic VC firms from 2014 to 2016. Results show that the more investment events of VC cross-border syndication or the more partners of VC cross-border syndication, the more likely it is to have a significant positive impact on the innovation of domestic portfolio companies. CBQRC plays a mediating role between VC cross-border syndication on corporate innovation. Results remain robust after removing endogeneity using the instrumental variables approach and removing sample selection bias using Heckman two-stage regression. Results deepen the understanding of the relationship between VC cross-border syndication and corporate innovation and provide essential guidance to domestic VC firms promoting corporate innovation in open partnerships.Entities:
Keywords: corporate innovation; cross-border quadratic relationship closure; cross-border syndication; strategic cooperation relationship; venture capital
Year: 2022 PMID: 35936306 PMCID: PMC9355533 DOI: 10.3389/fpsyg.2022.921168
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Structure of the cross-border quadratic relationship closure.
Variable descriptions.
| Variables | Index | Definition | |
| Explained variable |
| Corporate innovation | The number of invention patents granted by domestic portfolio companies in the second and third years after receiving VC investment. |
| Explanatory variable |
| Number of investment events of domestic VC cross-border syndication | Cumulative number of investment events in which domestic VC cross-border syndication prior to investing in domestic companies. |
|
| Number of partners of domestic VC cross-border syndication | Cumulative number of partners of domestic VC cross-border syndication prior to investing in domestic companies. | |
| Mediation variable |
| Cross-border quadratic relationship closure | The value is 1 if the domestic VC’s domestic portfolio company establishes a strategic cooperation partnership with a foreign company invested by foreign VC, who are cross-border syndication partners of domestic VC within the first year after receiving the investment, 0 otherwise. |
| Control variable |
| Successful exits | The cumulative number of domestic VC successful exits through M&A and IPO prior to investing in domestic companies. |
|
| IPO on foreign stock exchanges | The cumulative number of domestic VC exits through IPOs on foreign stock exchanges prior to investing in domestic companies. | |
|
| VC reputation | In the year of VC investment in domestic companies, 1 if the VC is listed in the annual ranking list of China equity investment published by Zero2IPO Group, 0 otherwise. | |
|
| State-owned background | 1 if the VC has a state-owned background, 0 otherwise. | |
|
| VC syndication size | When VC invests in domestic companies, 1 if the number of investors is greater than or equal to 2, 0 otherwise. | |
|
| Director assignment | Within the first year after the domestic portfolio company receives investment from domestic VC, 1 if domestic VC assigns directors to the domestic portfolio company, 0 otherwise. | |
|
| CEO replacement | Within the first year after the domestic portfolio company receives investment from domestic VC, 1 if domestic VC replaces the CEO of the domestic portfolio company with an experienced external CEO, 0 otherwise. | |
|
| Previous corporate Innovation | The total number of invention patents, utility model patents, and design patents applied for by domestic portfolio companies in the five years prior to receiving domestic VC investment. | |
|
| Hi-tech dummy | 1 if domestic portfolio company belongs to the high-tech industry, 0 otherwise. | |
|
| Early dummy | 1 if development stage of the domestic portfolio company is in the seed stage or start-up stage, 0 otherwise. | |
|
| Company age | The difference in years between the year the domestic portfolio company is founded and the deal year. |
Summary statistics.
| Variable | N | Mean value | Standard deviation | Minimum | Maximum |
| CI | 1,311 | 0.775 | 8.244 | 0 | 237 |
| Ne | 1,311 | 2.479 | 11.240 | 0 | 163 |
| Np | 1,311 | 13.841 | 61.635 | 0 | 634 |
| CBQRC | 1,311 | 0.046 | 0.209 | 0 | 1 |
| Se | 1,311 | 1.107 | 7.039 | 0 | 91 |
| IPO | 1,311 | 0.295 | 2.432 | 0 | 41 |
| Rep | 1,311 | 0.074 | 0.262 | 0 | 1 |
| Sob | 1,311 | 0.291 | 0.455 | 0 | 1 |
| Syn | 1,311 | 0.223 | 0.416 | 0 | 1 |
| Da | 1,311 | 0.320 | 0.467 | 0 | 1 |
| CEO | 1,311 | 0.022 | 0.147 | 0 | 1 |
| Pci | 1,311 | 1.849 | 7.367 | 0 | 54 |
| Tech | 1,311 | 0.613 | 0.487 | 0 | 1 |
| Early | 1,311 | 0.718 | 0.450 | 0 | 1 |
| Age | 1,311 | 2.841 | 4.357 | 0 | 36 |
Baseline regression results.
| Variables | Model (1) | Model (2) | Model (3) | Model (4) | Model (5) | Model (6) |
|
| ||||||
| CI | CI | CBQRC | CBQRC | CI | CI | |
| Ne | 0.076 | 0.059 | 0.034 | |||
| (2.770) | (5.592) | (1.114) | ||||
| Np | 0.013 | 0.010 | 0.006 | |||
| (2.951) | (6.483) | (1.213) | ||||
| CBQRC | 3.425 | 3.374 | ||||
| (3.379) | (3.354) | |||||
| Se | 0.026 | 0.026 | 0.037 | 0.039 | −0.018 | −0.017 |
| (0.706) | (0.703) | (2.397) | (2.676) | (−0.402) | (−0.377) | |
| IPO | −0.074 | −0.034 | 0.013 | 0.023 | −0.045 | −0.027 |
| (−0.764) | (−0.357) | (0.175) | (0.320) | (−0.413) | (−0.257) | |
| Rep | −1.803 | −1.989 | 0.935 | 0.680 | −1.720 | −1.813 |
| (−1.528) | (−1.710) | −1.914 | −1.393 | (−1.570) | (−1.657) | |
| Sob | −0.206 | −0.206 | −0.384 | −0.374 | 0.005 | 0.004 |
| (−0.559) | (−0.561) | (−0.895) | (−0.864) | (0.013) | (0.011) | |
| Syn | 1.969 | 1.975 | 0.468 | 0.503 | 2.033 | 2.038 |
| (4.106) | (4.126) | (1.406) | (1.505) | (4.641) | (4.651) | |
| Da | 2.073 | 2.077 | 0.901 | 0.935 | 1.342 | 1.348 |
| (5.887) | (5.92) | (2.886) | (2.988) | (3.708) | (3.726) | |
| CEO | 1.857 | 1.916 | 0.974 | 0.977 | 1.796 | 1.827 |
| (1.360) | (1.402) | (0.942) | (0.944) | (1.350) | (1.372) | |
| Pci | 0.049 | 0.049 | 0.034 | 0.033 | 0.055 | 0.055 |
| (2.176) | (2.170) | (2.805) | (2.644) | (2.388) | (2.387) | |
| Tech | 2.036 | 2.043 | 0.855 | 0.952 | 1.697 | 1.703 |
| (5.468) | (5.492) | (2.444) | (2.706) | (4.847) | (4.862) | |
| Early | −1.281 | −1.285 | 0.091 | 0.08 | −1.157 | −1.159 |
| (−2.371) | (−2.382) | (0.180) | (0.159) | (−2.499) | (−2.502) | |
| Age | −0.020 | −0.020 | −0.012 | −0.010 | −0.074 | −0.074 |
| (−0.351) | (−0.354) | (−0.252) | (−0.199) | (−1.459) | (−1.447) | |
| Constant | −4.108 | −4.111 | −6.154 | −6.196 | −3.614 | −3.623 |
| (−5.484) | (−5.492) | (−8.528) | (−8.483) | (−5.412) | (−5.420) | |
| Year FE | Yes | Yes | Yes | Yes | Yes | Yes |
| Log likelihood | −596.728 | −596.388 | −142.53 | −141.195 | −588.298 | −588.199 |
| N | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 |
The values in parentheses are z-statistics. *p < 0.1, **p < 0.05, ***p < 0.01.
Robustness checks for the endogenous problems.
| Variables | First stage | Second stage | ||||||
| Model (1) | Model (2) | Model (3) | Model (4) | Model (5) | Model (6) | Model (7) | Model (8) | |
|
| ||||||||
| Ne | Np | CI | CI | CBQRC | CBQRC | CI | CI | |
| Prie | 0.758 | 4.586 | ||||||
| (11.322) | (13.054) | |||||||
| Ne | 0.227 | 0.059 | 0.180 | |||||
| (2.562) | (2.661) | (1.810) | ||||||
| Np | 0.038 | 0.009 | 0.030 | |||||
| (2.578) | (2.332) | (1.819) | ||||||
| CBQRC | 5.773 | 5.967 | ||||||
| (2.873) | (3.114) | |||||||
| Controls | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Year FE | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Underidentification test | 117.996 | 152.35 | ||||||
| Cragg-Donald | 128.183 | 170.41 | ||||||
| Stock-Yogo critical value | 16.38 | 16.38 | ||||||
| N | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 |
In the first-stage regression, the values in parentheses are the t-statistics of the regression coefficients, and in the second-stage regression the values in parentheses are the z-statistics. *p < 0.1, **p < 0.05, ***p < 0.01. The coefficients of the following variables are not reported due to space considerations: Se, IPO, Rep, Sob, Syn, Da, CEO, Pci, Tech, Early, Age.
Robustness checks for the sample selection bias.
| Variables | First stage | Second stage | ||||||
| Model (1) | Model (2) | Model (3) | Model (4) | Model (5) | Model (6) | Model (7) | Model (8) | |
| AI | AI | CI | CI | CBQRC | CBQRC | CI | CI | |
| Imd | 0.378 | 0.378 | ||||||
| (9.727) | (9.727) | |||||||
| Ne | −0.000 | 0.080 | 0.058 | 0.035 | ||||
| (−0.024) | (2.883) | (5.471) | (1.151) | |||||
| NP | −0.000 | 0.014 | 0.010 | 0.006 | ||||
| (−0.028) | (3.067) | (6.413) | (1.250) | |||||
| CBQRC | 3.461 | 3.409 | ||||||
| (3.409) | (3.382) | |||||||
| Imr | 2.348 | 2.357 | −1.686 | −1.461 | 2.351 | 2.349 | ||
| (1.368) | (1.374) | (−1.101) | (−0.952) | (1.498) | (1.496) | |||
| Controls | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Year FE | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Log likelihood | −6137.866 | −6137.866 | −595.737 | −595.381 | −141.707 | −140.517 | −587.209 | −587.107 |
| N | 56,274 | 56,274 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 | 1,311 |
The values in parentheses are z-statistics. *p < 0.1, **p < 0.05, ***p < 0.01. The coefficients of the following variables are not reported due to space considerations: Se, IPO, Rep, Sob, Syn, Da, CEO, Pci, Tech, Early, Age.